[1] Wang F,Wang G,Liu T,et al.B7-H3 was highly expressed in human primary hepatocellular carcinoma and promoted tumor progression.Cancer Invest,2014,32:262-271. [2] Tezuka M,Hayashi K,Kubota K,et al.Growth rate of locally recurrent hepatocellular carcinoma after transcatheter arterial chemoembolization:comparing the growth rate of locally recurrent tumor with that of primary hepatocellular carcinoma.Dig Dis Sci,2007,52:783-788. [3] Sauzay C,Petit A,Bourgeois AM,et al.Alpha-foetoprotein (AFP):A multi-purpose marker in hepatocellular carcinoma.Clin Chim Acta,2016,463:39-44. [4] Gao J,Song P.Combination of triple biomarkers AFP,AFP-L3,and PIVAKII for early detection of hepatocellular carcinoma in China:Expectation.Drug Discov Ther,2017,11:168-169. [5] Wu M,Liu Z,Zhang A,et al.Associated measurement of fucosylated levels of AFP,DCP,and GPC3 for early diagnosis in hepatocellular carcinoma.Int J Biol Markers,2019,34:20-26. [6] 安松林,荣维淇,王黎明,等.甲胎蛋白阴性和甲胎蛋白阳性肝细胞癌临床病理特征及R0切除后生存分析.中华肿瘤杂志,2015,37:308-311. [7] Wang T,Liu M,Zheng SJ,et al.Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.World J Gastroenterol,2017,23:3496-3504. [8] Sun J,Zhao Y,Qin L,et al.Metabolomic profiles for HBV related hepatocellular carcinoma including Alpha-Fetoproteins positive and negative subtypes.Front Oncol,2019,9:1069. [9] Xu J,Liu C,Zhou L,et al.Distinctions between clinicopathological factors and prognosis of alpha-fetoprotein negative and positive hepatocelluar carcinoma patients.Asian Pac J Cancer Prev,2012,13:559-562. [10] Yoon YM,Kang DY,Kim DY,et al.Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy:a case report.J Med Case Rep,2016,10:140. [11] Yang S,Liu L,Luo Y,et al.Lower alpha fetoprotein and higher risk of hepatocellular carcinoma,study from the type 2 diabetes mellitus patients.Diabetes Res Clin Pract,2018,143:239-244. [12] 徐斌,李锐,郭燕丽,等.瞬时弹性测定评估甲胎蛋白阴性的慢性乙型病毒性肝炎患者发生原发性肝细胞癌风险的价值.中华医学超声杂志(电子版),2015,:301-305. [13] Schellhaas B,Wildner D,Pfeifer L,et al.LI-RADS-CEUS-proposal for a contrast-enhanced ultrasound algorithm for the diagnosis of hepatocellular carcinoma in high-risk populations.Ultraschall Med,2016,37:627-634. [14] Li R,Yang D,Tang CL,et al.Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors:clinical characteristics,imaging features of contrast-enhanced ultrasound and computed tomography.BMC Cancer,2016,16:158. [15] Tang D,Nagano H,Nakamura M,et al.Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma:a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.J Gastrointest Surg,2006,10:987-998. |